Leveraged Buyouts

UPDATE: Elan Rejects Fresh Bid from Royalty

Elan rejects the newest bid from Royalty and seeks to look at other unsolicited interested parties.


AstraZeneca Acquires Pearl Therapeutics for US$1.15 Billion

AstraZeneca purchases Pearl Therapeutics for US$1.15 billion, making it the second firm in Britain to rebuild products through deal making.

UPDATE: Unless Severn Trent Engages in Discussion, Bid Consortium Will Walk Away

LongRiver Consortium will walk away from the proposed US$8.2 million bid unless Severn Trent engages in discussion with the company.

Marubeni Leaves Energy Arm In Gavilon’s Deal

Japan’s Marubeni said that it will leave Gavilon’s energy arm from the proposed takeover deal. (Photo : REUTERS)Logo of Marubeni Corp is seen at the company's head office in Tokyo Marubeni Corp, a Japanese trading house states that it will cut its planned takeover deal over Gavilon's energy business.


Latest News

Severn Trent rejected the raised bid from LongRiver consortium. (Photo : Reuters)The image is the corporate logo of Severn Trent Services. Severn Trent, a British water firm rejected the increased US$8.
Fiat SpA can technically head off the Chrysler IPO through a buyout according to its CEO Sergio Marchionne.
Mediaquest acquires AME Info and SME Info with many buyout provisions affecting current operations and staff complement.
Berkshire Hathaway expressed interest in purchasing assets owned by Unipol. (Photo : Reuters)Berkshire Hathaway's fourth-quarter profit plunged sharply in part on an underwriting loss in its reinsurance business related to life insurance.
Dillon, the owner of Chateau Haut-Brion acquires nearby Chateau L'Arrosee. (Photo : Reuters)The image is the standard wine tasting done during a wine auction.
US Bankruptcy Court Judge, Christopher Sontchi granted planned acquisition deal without legal challenge between Micron Technologies Inc. and Elpida Memory Inc.
Marubeni Corp. is in advanced discussions to takeover Gavilon's energy division at US$5.6 billion.
The Federal Communications Commission through its website announces no objection with the SoftBank offered bid of US$20.1 billion to acquire Sprint Nextel.
The Ontario Teachers Pension Plan will vote for the Sprint-SoftBank deal as it is the fifteenth biggest shareholder in Sprint Nextel Corp.
Royalty Pharma raised its hostile bid for Irish drug firm, Elan from US$12.50 to US$13. (Photo : Reuters)The image is the corporate logo of Royalty Pharma, the healthcare focused equity fund.
Real Time Analytics